Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Intercept Pharmaceuticals, Inc. - Common Stock
(NQ:
ICPT
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Intercept Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Intercept Pharmaceuticals: Q1 Earnings Insights
↗
May 06, 2022
Intercept Pharmaceuticals (NASDAQ:ICPT) reported its Q1 earnings results on Friday, May 6, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
83 Biggest Movers From Yesterday
↗
May 06, 2022
Gainers Hudson Technologies, Inc. (NASDAQ: HDSN) shares jumped 26.9% to close at $9.06 on Thursday after the company reported better-than-expected Q1 EPS and sales results.
Via
Benzinga
Why Intercept Shares Are Rising Today
↗
May 05, 2022
Intercept Pharmaceuticals Inc (NASDAQ: ICPT) has
Via
Benzinga
Intercept Pharma Scores $450 Million Deal For Its Flagship Liver Drug
↗
May 05, 2022
A U.K.-based pharmaceutical company will sell Ocaliva outside the U.S.
Via
Investor's Business Daily
Earnings Scheduled For May 6, 2022
↗
May 06, 2022
Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEP) is expected to report quarterly loss at $0.02 per share on revenue of $1.27 billion.
Via
Benzinga
Earnings Outlook For Intercept Pharmaceuticals
↗
May 05, 2022
Intercept Pharmaceuticals (NASDAQ:ICPT) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Drops 650 Points; Silicon Motion Shares Spike Higher
↗
May 05, 2022
U.S. stocks remained lower toward the end of trading, with the Nasdaq Composite dropping more than 650 points on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
May 05, 2022
Via
Benzinga
Dow Sheds Nearly 1,000 Points as Selloff Deepens
↗
May 05, 2022
Stocks are sharply lower at midday, in what is shaping up to be another volatile day on Wall Street.
Via
Talk Markets
Mid-Day Market Update: U.S. Stocks Extend Losses; Dow Dips Over 1,100 Points
↗
May 05, 2022
U.S. stocks extended losses midway through trading, with the Dow Jones dipping more than 1,100 points on Thursday.
Via
Benzinga
57 Stocks Moving In Thursday's Mid-Day Session
↗
May 05, 2022
Gainers
Via
Benzinga
Why Is Intercept Pharmaceuticals (ICPT) Stock Up Today?
↗
May 05, 2022
Intercept Pharmaceuticals (ICPT) stock is soaring higher on Thursday after the biopharmaceutical company revealed a deal with Advanz Pharma.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
May 05, 2022
Via
Benzinga
Intercept Pharmaceuticals Q1 2022 Earnings Conference Call On May 6, 2022 At 08:30 AM ET
↗
May 03, 2022
Intercept Pharmaceuticals (NASDAQ:ICPT) will host a conference call at 08:30 AM ET on May 6, 2022, to discuss Q1 2022 earnings results.
Via
Benzinga
7 Potential Biotech Stocks Buyout Targets in 2022
↗
April 21, 2022
Drug development is a cumbersome process and M&A is a win-win proposition for both the acquirer and the target company.
Via
InvestorPlace
Short-Squeeze Stocks: Top 10 Stocks With High Short Interest Today
↗
March 15, 2022
Short-squeeze stocks continue to be a hot topic with retail traders and we're going over the top ones to keep an eye on for Tuesday!
Via
InvestorPlace
Looking Into Intercept Pharmaceuticals's Return On Capital Employed
↗
March 08, 2022
Intercept Pharmaceuticals (NASDAQ:ICPT) brought in sales totaling $92.40 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 898.9%,...
Via
Benzinga
Analyst Ratings For Intercept Pharmaceuticals
↗
March 03, 2022
Analysts have provided the following ratings for Intercept Pharmaceuticals (NASDAQ:ICPT) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
March 02, 2022
Gainers IsoPlexis (NASDAQ:ISO) shares moved upwards by 22.8% to $5.5 during Wednesday's pre-market session. The company's market cap stands at $214.2 million. The...
Via
Benzinga
Intercept Pharmaceuticals: Q4 Earnings Insights
↗
March 02, 2022
Intercept Pharmaceuticals (NASDAQ:ICPT) reported its Q4 earnings results on Wednesday, March 2, 2022 at 07:00 AM. Here's what investors need to know about the...
Via
Benzinga
The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi
↗
March 02, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Karyopharm Says FDA Mandates Additional Study For Expanding Selinexor Label...
Via
Benzinga
Earnings Preview For Intercept Pharmaceuticals
↗
March 01, 2022
Intercept Pharmaceuticals (NASDAQ:ICPT) is set to give its latest quarterly earnings report on Wednesday, 2022-03-02. Here's what investors need to know before the announcement....
Via
Benzinga
Earnings Scheduled For March 2, 2022
↗
March 02, 2022
Companies Reporting Before The Bell • SIGNA Sports United (NYSE:SSU) is expected to report quarterly loss at $0.04 per share on revenue of $283.61 million. •...
Via
Benzinga
Short Squeeze Activity: New Players, Same Game, Different Results
↗
February 01, 2022
Short squeezes will remain a big story in the financial news media until heavily shorted stocks that have been pushed up by individual investors come crashing back to earth.
Via
Talk Markets
B. Riley Beefs Up Intercept Target Price On Catalyst Rich 1H 2022
↗
January 11, 2022
B. Riley upgraded Intercept Pharmaceuticals Inc (NASDAQ: ICPT) to Buy from Neutral with a price target of $30, up from $25. Analyst Mayank Mamtani sees...
Via
Benzinga
Top Short Squeeze Plays
↗
December 20, 2021
Since the market has dropped so much, now might be the time to look for short squeeze opportunities.
Via
Talk Markets
The 10 Most Shorted Stocks Right Now for Friday, Dec. 17
↗
December 17, 2021
Shorted stocks continue to be of interest to retail traders looking for the next big day trade and we're diving into some top candidates!
Via
InvestorPlace
Why Are Intercept Pharmaceuticals Shares Falling Today?
↗
December 09, 2021
Intercept Pharmaceuticals Inc (NASDAQ: ICPT) has withdrawn its European marketing application seeking approval for obeticholic acid (OCA) for liver fibrosis due to...
Via
Benzinga
63 Biggest Movers From Friday
↗
December 20, 2021
Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15...
Via
Benzinga
56 Biggest Movers From Yesterday
↗
December 10, 2021
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares jumped 84% to close at $4.95 on Thursday after the company signed an exclusive summary distribution agreement...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today